news
New drug targets for a rare kidney and liver disease
In a joint international study, researchers have collaborated to uncover how mutations in a single gene called PKHD1 lead to symptoms associated with a rare kidney and liver disease...
List view / Grid view
Kidney disease
news
Potential new drug target for polycystic kidney disease
28 June 2016 | By Victoria White, Digital Content Producer
Researchers have used virtual tissue technology to identify a potential new drug target in the fight against polycystic kidney disease...
news
DNA from 20,000 people to help discover new treatments for diabetic kidney disease
3 June 2016 | By Victoria White, Digital Content Producer
Researchers are to examine DNA samples from 20,000 people with diabetes to help identify the genetic factors in diabetic kidney disease...
news
Urine of premature babies a novel source of kidney stem cells
7 March 2016 | By Victoria White
A team, led by Professor Elena Levtchenko from KU Leuven, discovered that kidney stem cells are abundant in the urine of premature babies...
news
Variant and L&F Research to advance development of VAR 200
18 December 2015 | By Victoria White
Variant says VAR 200 has potential for treating multiple indications associated with the damaging effects of cellular accumulation of cholesterol and lipids on the kidney, including focal segmental glomerulosclerosis...
news
Disease recreated in mini-kidney organoids in the lab
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
news
Researchers turn stem cells into mini-kidneys
8 October 2015 | By Victoria White
The breakthrough could allow the use of mini-organs to screen drugs either for the treatment of kidney disease or to find out if a new drug is likely to injure the kidney...
news
AstraZeneca and Inserm collaborate to investigate new therapeutic approaches to diabetes and CKD
17 June 2015 | By Victoria White
AstraZeneca is to collaborate with Inserm to investigate new therapeutic approaches to type 2 diabetes and Chronic Kidney Disease (CKD)...
news
TSRI scientists win $2.2 million to expand study of IP6K1 to help develop new obesity therapies
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
news
Hydra Biosciences and Boehringer Ingelheim collaborate to research treatments for renal diseases and disorders
14 April 2015 | By Victoria White
Hydra Biosciences and Boehringer Ingelheim have entered into a research collaboration with a primary focus on the treatment of renal diseases and disorders...
news
Amgen announces positive Phase 3 results for AMG 416 for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease receiving hemodialysis
18 July 2014 | By Amgen
Analysis shows study met primary and all secondary endpoints AMG 416 is a novel calcimimetic administered intravenously...
news
DaVita Labs and Myriad RBM announce biomarker research collaboration
7 July 2014 | By Myriad RBM
Collaboration will focus on development of novel diagnostic tests for dialysis patients...
news
New phase 3 study shows efficacy and safety of Victoza® for the treatment of type 2 diabetes in adults with moderate renal impairment
16 June 2014 | By Novo Nordisk
Data from a new phase 3 study demonstrated that once-daily Victoza® (liraglutide) provided greater glycaemic control versus placebo with no worsening of renal function in adults with type 2 diabetes and moderate renal impairment...